The return is the overall income an investor receives from his or her investment each year, and it is commonly expressed as a percentage of the initial investment value. When dividends are distributed, the investor often receives a return on his or her investment in shares or an investment portfolio.
Here are the 3 stocks that gave a return of 46.58 percent in just 5 years.
Sobha Ltd
Sobha Limited is a real estate developer that builds and operates townships, housing complexes, commercial properties, and other associated ventures. The company also manufactures interiors, glazing, and concrete products.
With a market capitalization of Rs 12,040.21 crore, the shares closed at Rs 1,270.25 per share, decreasing around 2.16 as compared to the previous closing price of Rs 1,297.50 apiece. The stock gave a return of 27.69 percent in the last few days.
Sobha Ltd’s revenue increased 10 percent from Rs. 670 crores in Q2FY23 to Rs 741 crores in Q2FY24. Further, During the same time frame, Net Profit decreased by 21 percent from Rs 19 crores to Rs 15 crores.
Integra Essentia Ltd
Integra Essentia Ltd operates in the Life Essentials sector, which includes Food (Agro Products), Clothing (Textiles and Garments), Infrastructure (Materials and Services for Construction and Infrastructure Development), and Energy (Materials, Products, and Services).
With a market capitalization of Rs 489.48 crore, the shares closed at Rs 10.71 per share, decreasing around 8.54 as compared to the previous closing price of Rs 11.71 apiece. The stock gave a return of 46.58 percent in the last few days.
Integra Essentia Ltd’s revenue increased 17 percent from Rs. 57.13 crores in Q2FY23 to Rs 66.90 crores in Q2FY24. Further, During the same time frame, Net Profit increased by 267 percent from Rs 2.05 crores to Rs 7.54 crores.
Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company Ltd is a pharmaceutical product research and development (R&D) company.
With a market capitalization of Rs 13,686.70 crore, the shares closed at Rs 421.75 per share, increasing around 9.52 as compared to the previous closing price of Rs 385.10 apiece. The stock gave a return of 45.33 percent in the last few days.
Sun Pharma Advanced Research Company Ltd’s revenue decreased 34 percent from Rs. 32 crores in Q2FY23 to Rs 21 crores in Q2FY24. Further, During the same time frame, Net loss magnified from Rs 68 crores to Rs 86 crores.
Written by:- Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
